Theoretically, the two compounds target completely different receptor systems (amylin receptors for cagrilintide, GLP-1/GIP/glucagon for retatrutide), which suggests they could work synergistically without receptor overlap
They overlap mechanistically both contain BPC-157 and TB-500 but the Glow Blend adds GHK-Cu as a third component, fundamentally changing what the formulation is studied for
Experts say consumers should be cautiouscompounded peptides are not FDA-approved, and more proven treatments may already be available
A rigorous 2026 UK review covering the September 2024 FDA approval of Bristol Myers Read the full review Trauma & Mental Health 14 May 2026 Dihexa for PTSD & Complex PTSD: Fear Extinction, BDNF & the 2026 UK Review Can Dihexa help PTSD or complex PTSD
Several reported effects, including stress-axis modulation, produced positive results in animals but negative results in humans (PMID 7777652)